Craig Robson

This inventor holds 6 USPTO granted patents. Top assignees: Ascensia Diabetes Care Holdings Ag, Bayer Healthcare LLC. Active years: 2014-2021.

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

4 out of 231

Ascensia Diabetes Care Holdings Ag

Years Active: 2014-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947328 - Polymer comprising a plurality of phenothiazine groups and methods of making the same (2021-03-16),

2. 10662264 - Polymer comprising a plurality of phenothiazine groups and methods of making the same (2020-05-26),

3. 9944725 - Polymer comprising a plurality of phenothiazine groups and methods of making the same (2018-04-17),

4. 9505884 - Polymer comprising a plurality of phenothiazine groups and methods of making the same (2016-11-29),

5. 9238717 - Polymer comprising a plurality of phenothiazine groups and methods of making the same (2016-01-19),

6. 8742063 - Polymer bonded redox molecules and methods of making the same (2014-06-03),

Title: Craig Robson: Innovator in Polymer Technology

Introduction

Craig Robson is a notable inventor based in Camelford, GB. He has made significant contributions to the field of polymer technology, holding a total of 6 patents. His work focuses on innovative solutions that enhance the functionality of polymers in various applications.

Latest Patents

One of Craig Robson's latest patents is titled "Polymer comprising a plurality of phenothiazine groups and methods of making the same." This invention describes a non-leaching mediator that includes a polymer with a polymeric backbone and a plurality of phenothiazine groups bonded to it. The phenothiazine groups may include specific structures that enhance the polymer's properties, making it suitable for advanced applications.

Career Highlights

Throughout his career, Craig has worked with prominent companies such as Ascensia Diabetes Care Holdings AG and Bayer Healthcare LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in polymer technology.

Collaborations

Craig has collaborated with talented individuals in his field, including Jiangfeng Fei and William Chiang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Craig Robson's work in polymer technology exemplifies the spirit of innovation and dedication to advancing scientific knowledge. His contributions continue to impact the industry positively, showcasing the importance of inventors in driving progress.